APGN
|Apexigen Inc.
NASDAQ
USD
|%
Current Price
Change
(%)
P/E Ratio
Dividend Yield
Market Cap
9.57M
Volume
Open
Previous Close
52-Week High
52-Week Low
About Apexigen Inc.
Apexigen, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonis...
Sector:Healthcare
Industry:Biotechnology
CEO:Dr. Xiaodong Yang M.D., Ph.D.
Employees:11
Headquarters:San Carlos, USA
Website:www.apexigen.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions